top of page
  • decodeMR Team

The Complexities of Thyroid Cancer: Insights on Clinical Behavior and Care: Q & A Session with an Expert

Episode summary

Welcome to the new episode of Inline! 

In this episode, we talk to Dr. Rajendra Arora, a renowned medical oncologist at Sujan Surgical Cancer Hospital and Amravati Cancer Foundation, about the complexities of thyroid cancer. 

How do we differentiate between slow-growing and aggressive thyroid tumors? What role do biomarkers play in identifying more severe forms of thyroid cancer? Dr. Arora discusses the variable clinical behavior of thyroid cancer, highlighting the unique challenges of treating various types and the promising advancements in immunotherapy. 

Dr. Arora also highlights the bidirectional relationship between thyroid and breast cancer. He shares insights on how patients with one type of cancer should be vigilant about the other. Additionally, we discuss the importance of early detection and the impact of supportive care in improving the quality of life for thyroid cancer patients. 

Key discussion points: 

  1. Variable Clinical Behavior of Thyroid Cancer (0:39) 

  • Thyroid cancer can range from slow growing to highly aggressive forms 

  • Prognosis depends on factors like age and type of cancer (follicular, papillary, undifferentiated) 

2. Differentiating Thyroid Cancer Types (1:31) 

  • Follicular carcinoma spreads through the hematogenous route and has a poorer prognosis 

  • Papillary carcinoma is usually slow growing with good long-term survival rates 

  • Undifferentiated carcinoma presents with rapid metastasis and has a very poor prognosis 

3. Role of Biomarkers (3:54) 

  • Biomarkers like thyroglobulin and Ki-67 have been used but with varying effectiveness

  • Emerging biomarkers (e.g., lncRNAs, MALAT1) show potential but are not widely accessible 

4. Bidirectional Relationship with Breast Cancer (6:06)

  • Women with thyroid cancer have higher risk of developing breast cancer and vice versa 

  • This correlation is likely hormone-related rather than due to radiotherapy 

5. Treatment Approaches (7:43)

  • Thyroid cancer treatments include total thyroidectomy followed by radioactive iodine therapy 

  • Follicular and undifferentiated carcinomas require more aggressive and symptomatic treatments 

  • Emerging treatments include immunotherapy and targeted therapies, although effectiveness varies 

6. Promising Future Advancements (9:00) 

  • Anticipation of new immunotherapies similar to those developed for other cancers (e.g., Herceptin for breast cancer) 

  • Ongoing research into treatments for advanced and metastatic thyroid cancer 

7. Supportive Care (11:46) 

  • Essential for improving quality of life for thyroid cancer patients 

  • Includes interventions for respiratory difficulties, feeding support, and symptomatic relief 

8. Importance of Early Detection (12:39) 

  • Early diagnosis and treatment significantly improve prognosis 

  • Patients should not delay seeking treatment for thyroid swellings 

Take Home Messages:

  • Seek medical advice promptly for any thyroid swellings to improve chances of cure 

  • Treatment varies based on cancer type and progression. Personalized approaches are crucial 

  • Continued research into immunotherapies and novel treatments offers hope for better outcomes in the future 

  • Supportive care is vital for managing symptoms and enhancing quality of life, especially in advanced stages 

  • Understand the potential bidirectional relationship between thyroid and breast cancer for better monitoring and prevention 

About Dr. Rajendra Arora:

Dr. Rajendra Arora is a consultant medical oncologist at Sujan Surgical Cancer Hospital and Amravati Cancer Foundation.  

Relevant links: 


bottom of page